Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01165437 · ClinicalTrials.gov registry record

Validation of a Novel Oscillometric-Based Algorithm for Determination of the Ankle-Brachial Index

A clinical trial of Peripheral Arterial Disease, sponsored by Summit Doppler Systems.

Completed
Registry status
161
Enrollment target
1
Study location

NCT01165437 is a study of Peripheral Arterial Disease that has completed, run by Summit Doppler Systems. The registered enrollment target is 161 participants, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01165437, a study of Peripheral Arterial Disease, has completed, sponsored by Summit Doppler Systems.

COMPLETED
Registry status
161 participants
Enrollment target
1
Study location

Study Summary

Peripheral arterial disease (PAD) is a highly prevalent medical condition. Patients with PAD are usually diagnosed on the basis of the ankle-brachial index. The ankle-brachial index is the ratio of ankle pressure to arm pressure after measurement of blood pressures in the arms and legs using a Doppler device. The need for dedicated equipment and trained personnel, along with the time required to perform the test, have been identified as barriers to widespread implementation of ankle-brachial index screening. The use of automated oscillometric devices for blood pressure measurement has been applied to leg pressure measurement and determination of the ankle-brachial index with variable success. It will be beneficial to investigate a reliable oscillometric-based procedure that can accurately measure leg pressures for the ankle-brachial index across the entire spectrum of PAD severity. In a previous pilot study completed in 2009 (IRB 08-823), the investigators gathered data from N=60 subjects which allowed for mathematical analysis of oscillometric waveforms derived from the lower extremities as compared to Doppler-based measurements of blood pressure. We used signal processing analysis and regression techniques to develop a two-step algorithm which will allow for accurate interpretation of oscillometric waveforms in normal/mild vs. moderate/severely diseased limb and accurate calculation of ankle pressure across the spectrum of peripheral artery disease severity. This proposed project will validate this novel oscillometric ABI algorithm in a population of patients who have been identified as at risk for PAD and for whom screening ABI has been recommended by multiple professional organizations (AHA/ACC and American Diabetes Association). Arm, ankle, and toe pressure measurements will be made in the supine position using Doppler, oscillometric methods, and a photoplethysmographic sensor. The ankle-brachial index and toe-brachial index will be calculated.

Interventions

  • DEVICE Blood Pressure Measurement

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 161 participants
Start Date 2010-10
Est. Completion 2011-01

Sponsor

Summit Doppler Systems

2 total trials

What the Registry Record Tells You About NCT01165437

The ClinicalTrials.gov registry entry for NCT01165437 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (96% lower). The listed sponsor is Summit Doppler Systems, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Blood Pressure Measurement is the first listed.

NCT01165437 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01165437 about?

NCT01165437 is a clinical study titled "Validation of a Novel Oscillometric-Based Algorithm for Determination of the Ankle-Brachial Index". Peripheral arterial disease (PAD) is a highly prevalent medical condition. Patients with PAD are usually diagnosed on the basis of the ankle-brachial index. The ankle-brachial index is the ratio of ankle pressure to arm pressure after measurement of blood pressures in the arms and legs using a Doppl...

What is the current status of trial NCT01165437?

This trial is currently completed. The enrollment target is 161 participants. The study started on 2010-10. Estimated completion is 2011-01.

What conditions does trial NCT01165437 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease.

What interventions are being tested in trial NCT01165437?

The interventions under investigation include: Blood Pressure Measurement (DEVICE).

Who is sponsoring clinical trial NCT01165437?

This trial is sponsored by Summit Doppler Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01165437 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Arterial Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.